Is the fat anterior to the psoas (muscle) below the lower pole of the kidney an uncommon location for lymph node metastasis in kidney cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, the fat anterior to the psoas muscle below the lower pole of the kidney is not an uncommon location for lymph node metastasis in kidney cancer. This area contains perirenal and paraaortic lymph nodes that are frequent sites of metastatic spread from renal cell carcinoma. Kidney cancer typically spreads via lymphatic channels to regional lymph nodes, including those located in the retroperitoneal space anterior to the psoas muscle. The lymphatic drainage of the kidney follows a predictable pattern, with efferent lymphatic vessels traveling alongside the renal vein and draining into these retroperitoneal lymph nodes 1. During surgical management of kidney cancer, particularly radical nephrectomy, lymph node dissection in this area is often performed for staging and therapeutic purposes. Imaging studies such as CT scans with contrast frequently evaluate this region specifically when assessing for metastatic spread of kidney cancer, as enlarged or abnormal-appearing lymph nodes in this location may represent metastatic disease. The most recent study from 2017 1 provides insight into the biology of clear cell renal cell carcinoma, which is the most common subtype of kidney cancer, and highlights the importance of understanding the lymphatic spread of the disease. Key points to consider in the management of kidney cancer include:

  • The role of lymph node dissection in surgical management
  • The importance of imaging studies in assessing for metastatic spread
  • The predictable pattern of lymphatic drainage of the kidney
  • The frequency of metastasis to perirenal and paraaortic lymph nodes. Overall, the fat anterior to the psoas muscle below the lower pole of the kidney is a common location for lymph node metastasis in kidney cancer, and its evaluation is crucial in the management of the disease.

From the Research

Lymph Node Metastasis in Kidney Cancer

  • The location of lymph node metastasis in kidney cancer can vary, but there is limited information on the specific location anterior to the psoas muscle below the lower pole of the kidney.
  • Studies on kidney cancer and lymph node metastasis do not provide direct evidence on the frequency of metastasis in this specific location 2, 3.
  • The tumor-node-metastasis (TNM) system is used to stage cancer, including kidney cancer, and takes into account the extent of lymph node metastases, but does not specify the location of these metastases 3.
  • There is no direct evidence to suggest that the fat anterior to the psoas muscle below the lower pole of the kidney is a common or uncommon location for lymph node metastasis in kidney cancer.
  • Other studies have focused on the diagnosis and treatment of conditions affecting the psoas muscle, such as lipomas, but do not provide information on lymph node metastasis in this location 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tumor Staging and Grading: A Primer.

Methods in molecular biology (Clifton, N.J.), 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.